Mega-Comparison: Hims vs Ro vs Calibrate vs Found vs Noom vs Sequence (2025)

With over a dozen telehealth platforms now offering GLP-1 medications for weight loss, choosing the right program can feel overwhelming. Each platform promises personalized care, competitive pricing, and effective results, but the reality varies dramatically across providers.

This comprehensive comparison evaluates six major GLP-1 weight loss programs based on pricing, medication options, physician oversight, shipping speed, and patient experience. We analyzed each platform's current offerings, pricing structures, and clinical approach to help you make an informed decision about your weight loss process.

Quick Verdict: Platform Comparison

Hims: What You Get

Hims positions itself as the straightforward option in the GLP-1 space, offering both semaglutide and tirzepatide through a streamlined telehealth platform. The company has expanded from its original men's health focus to become a major player in weight management, emphasizing simplicity and direct access to medications.

The pricing structure starts at $199 per month for semaglutide, with tirzepatide available at higher price points depending on dosage. This includes the medication, shipping, and basic physician oversight through their platform. The consultation process involves a comprehensive online assessment followed by a video or phone consultation with a licensed healthcare provider.

Hims sources its GLP-1 medications from FDA-registered compounding pharmacies, which allows for more flexible dosing options compared to brand-name medications. The platform provides standard injection supplies and basic educational materials about proper injection technique and side effect management.

The shipping timeline typically runs 3-5 business days via temperature-controlled packaging to maintain medication stability. Hims offers automatic refill scheduling and text message reminders to help patients maintain consistency with their treatment regimen.

Pros:

• Simple, no-frills approach to GLP-1 therapy
• Both semaglutide and tirzepatide available
• Flexible dosing through compounded medications
• Fast shipping and reliable delivery
• Established telehealth platform with good customer service

Cons:

• Higher pricing compared to some competitors
• Limited nutritional or lifestyle coaching
• Basic physician interaction model
• No comprehensive weight loss program beyond medication
• Limited insurance acceptance

Ro: What You Get

Ro (formerly Roman) has positioned itself as the budget-friendly option in the GLP-1 market, starting at $145 per month for semaglutide therapy. The platform emphasizes affordability while maintaining clinical oversight through licensed healthcare providers across all 50 states.

The consultation process begins with a detailed online health assessment covering medical history, current medications, weight loss goals, and lifestyle factors. Qualified patients then connect with a physician through the platform for prescription approval. Ro's medical team includes board-certified physicians specializing in obesity medicine and endocrinology.

Medication sourcing comes through FDA-registered compounding pharmacies, allowing for customized dosing protocols. The platform provides comprehensive injection training materials, including video tutorials and step-by-step guides. Patients receive pre-loaded syringes or pen injectors depending on their specific prescription.

Ro's shipping infrastructure ensures 3-5 day delivery with temperature monitoring throughout transit. The platform includes automatic prescription management, refill reminders, and 24/7 customer support for medication-related questions.

The platform recently expanded its offerings to include basic nutritional guidance and lifestyle modification resources, though these remain limited compared to comprehensive weight loss programs. Ro focuses primarily on medication access and clinical safety rather than extensive behavioral support.

Pros:

• Most affordable pricing in the market
• Licensed physicians in all 50 states
• Reliable medication sourcing and delivery
• Good customer service and platform usability
• Transparent pricing with no hidden fees

Cons:

• Minimal lifestyle coaching or support
• Basic physician interaction model
• Limited educational resources
• No comprehensive weight management program
• Restricted insurance options

Calibrate: What You Get

Calibrate takes a comprehensive approach to weight loss, combining GLP-1 medications with extensive lifestyle coaching, nutritional guidance, and behavioral support. The platform charges $1,649 annually (approximately $137 per month), positioning itself as a holistic weight management solution rather than just medication access.

The program begins with a detailed metabolic assessment, including lab work analysis and comprehensive health evaluation. Calibrate assigns each patient a dedicated care team including a physician, registered dietitian, and certified health coach. This team approach provides ongoing support throughout the weight loss process.

Medication options include both semaglutide and tirzepatide, sourced through the platform's pharmacy partnerships. Calibrate emphasizes the "Four Pillars" approach: medication, food, sleep, and exercise. The platform provides detailed tracking tools for each pillar, with regular check-ins and progress assessments.

The educational component includes access to registered dietitians for meal planning, sleep specialists for optimization strategies, and fitness professionals for exercise programming. Calibrate's app integrates with popular fitness trackers and provides real-time coaching based on user data.

Insurance acceptance varies by plan, but Calibrate works with many major insurers to cover both the program fees and medication costs. The platform provides prior authorization support and appeals assistance for insurance coverage.

Pros:

• Comprehensive lifestyle coaching program
• Dedicated care team approach
• Strong insurance acceptance and support
• Evidence-based behavioral modification techniques
• Extensive educational resources and tools

Cons:

• Higher upfront annual commitment
• More complex program may overwhelm some users
• Longer shipping times (5-7 days)
• Requires more time investment from patients
• Limited flexibility in program customization

Found: What You Get

Found focuses on combining GLP-1 medications with behavioral psychology and habit formation strategies. Priced at $149 per month, the platform emphasizes sustainable weight loss through both pharmaceutical intervention and psychological support.

The initial assessment includes psychological evaluation alongside medical history, helping to identify behavioral patterns that contribute to weight gain. Found assigns patients to specialized physicians who understand the psychological aspects of obesity and weight management.

The platform offers both semaglutide and tirzepatide through compounded formulations, with dosing adjusted based on patient response and tolerance. Found's unique approach includes regular behavioral coaching sessions focused on identifying triggers, developing coping strategies, and building sustainable habits.

Educational resources emphasize the psychological aspects of eating, including emotional eating patterns, stress management, and mindful eating techniques. The platform's app includes mood tracking, habit formation tools, and cognitive behavioral therapy techniques adapted for weight management.

Found works with insurance providers to cover medication costs and offers financial assistance programs for qualifying patients. The platform provides comprehensive support for prior authorization and insurance navigation.

Pros:

• Strong focus on behavioral psychology
• Specialized physicians with obesity medicine training
• Insurance support and financial assistance
• Comprehensive habit formation tools
• Evidence-based psychological interventions

Cons:

• May not appeal to users wanting medication-only approach
• Requires active participation in behavioral components
• Limited availability in some states
• Moderate pricing without premium features
• Newer platform with less established track record

Noom: What You Get

Noom leverages its established psychology-based weight loss platform to offer GLP-1 therapy, priced at $149 per month. The company combines its proven behavioral intervention app with semaglutide access, though tirzepatide is not currently available through their platform.

The program begins with Noom's signature psychological assessment, identifying cognitive patterns and behavioral triggers related to eating and weight management. This assessment feeds into a personalized coaching program that runs alongside GLP-1 therapy.

Noom's strength lies in its established behavioral modification platform, which includes daily lessons, food logging with psychological insights, and one-on-one coaching sessions. The platform uses cognitive behavioral therapy principles adapted specifically for weight management and eating behavior modification.

Medication access involves consultation with Noom's network of licensed physicians, though the medical component remains secondary to the behavioral intervention focus. Semaglutide is provided through compounding pharmacy partnerships with standard shipping timelines of 5-7 days.

The app integration provides seamless tracking of both medication effects and behavioral changes, with data visualization showing correlations between psychological factors and weight loss progress. Noom's large user community provides additional peer support and motivation.

Pros:

• Established, evidence-based behavioral platform
• Strong psychological intervention components
• Large community support network
• Comprehensive food and mood tracking
• Proven track record in behavioral weight loss

Cons:

• No tirzepatide availability
• Medical component feels secondary
• Longer shipping times
• May overwhelm users seeking simple medication access
• Limited physician interaction compared to medical-focused platforms

Sequence: What You Get

Sequence positions itself as the premium option in the GLP-1 space, charging $297 per month for comprehensive weight management services. The platform emphasizes personalized medicine, extensive physician oversight, and premium patient experience throughout the treatment plan.

The consultation process involves detailed metabolic testing, including comprehensive lab panels, body composition analysis, and genetic testing where appropriate. Sequence assigns patients to board-certified obesity medicine specialists who provide ongoing medical oversight and treatment optimization.

Both semaglutide and tirzepatide are available through multiple sourcing options, including both compounded and brand-name formulations depending on patient needs and insurance coverage. The platform provides premium injection supplies and comprehensive educational materials.

Sequence's care model includes regular physician check-ins, personalized nutrition planning with registered dietitians, and access to fitness professionals. The platform emphasizes medical optimization, including addressing underlying metabolic issues that contribute to weight gain.

Shipping is expedited at 2-3 days with premium packaging and temperature monitoring. The platform provides 24/7 medical support and immediate access to healthcare providers for urgent questions or side effect management.

Pros:

• Premium physician oversight and medical care
• Comprehensive metabolic testing and optimization
• Both compounded and brand-name medication options
• Fastest shipping and premium packaging
• 24/7 medical support availability

Cons:

• Highest pricing in the market
• May be excessive for straightforward cases
• Limited insurance acceptance
• Requires significant time investment
• Premium features may not justify cost for all patients

Price Comparison: Finding the Best Value

Pricing varies significantly across platforms, with monthly costs ranging from $145 to $297. However, direct price comparison can be misleading without considering the services included in each program.

Ro offers the lowest entry price at $145 monthly, focusing purely on medication access with basic physician oversight. This approach works well for patients who want straightforward GLP-1 therapy without additional coaching or support services.

Calibrate's annual pricing of $1,649 ($137 monthly) provides the best value for patients seeking comprehensive weight management. The platform includes extensive lifestyle coaching, nutritional guidance, and behavioral support that would cost significantly more if purchased separately.

Found and Noom both price at $149 monthly, positioning themselves in the middle market with enhanced behavioral support beyond basic medication access. These platforms provide good value for patients who want psychological intervention alongside pharmaceutical treatment.

Hims at $199 monthly represents a premium for simplicity and brand recognition, while Sequence at $297 monthly targets patients seeking premium medical care and personalized optimization.

Insurance coverage varies dramatically across platforms. Calibrate and Found offer the strongest insurance support, potentially reducing out-of-pocket costs significantly. Other platforms typically require cash payment with limited insurance acceptance.

Medication Options: Semaglutide vs Tirzepatide Availability

Most platforms offer semaglutide, the GLP-1 receptor agonist that has shown 12-15% average weight loss in clinical trials (Wilding et al., NEJM, 2021). However, tirzepatide availability varies significantly across platforms.

Tirzepatide, which targets both GLP-1 and GIP receptors, has demonstrated superior weight loss outcomes with average reductions of 15-20% in clinical studies (Jastreboff et al., NEJM, 2022). Hims, Ro, Calibrate, Found, and Sequence all offer tirzepatide options, while Noom currently provides only semaglutide.

Medication sourcing differs across platforms. Most utilize FDA-registered compounding pharmacies, which allows for flexible dosing and potentially lower costs. However, some platforms like Sequence also offer brand-name formulations (Ozempic, Wegovy, Mounjaro, Zepbound) when insurance coverage is available.

Dosing protocols vary based on platform approach and physician preferences. Compounded medications allow for more granular dose adjustments, which can be beneficial for managing side effects and optimizing efficacy. Brand-name medications follow standard FDA-approved dosing schedules.

Quality control measures are important considerations when evaluating compounded vs. brand-name options. Reputable platforms work exclusively with FDA-registered 503B compounding facilities that follow strict quality standards and undergo regular inspections.

Doctor Quality and Oversight

Physician oversight varies dramatically across platforms, from basic prescription management to comprehensive medical care. Understanding these differences is crucial for patient safety and treatment optimization.

Basic oversight platforms like Hims, Ro, and Noom provide initial consultations and prescription management through licensed physicians. Follow-up care typically involves questionnaire-based check-ins with limited direct physician interaction.

Enhanced oversight platforms like Calibrate and Found assign dedicated physicians who provide regular consultations, side effect management, and treatment optimization. These platforms emphasize ongoing medical relationships rather than transactional prescription services.

Premium oversight from Sequence includes board-certified obesity medicine specialists, comprehensive metabolic evaluation, and intensive medical monitoring. This level of care is appropriate for complex cases or patients with multiple comorbidities.

Physician qualifications vary across platforms. Some utilize family medicine or internal medicine physicians with basic weight management training, while others employ board-certified obesity medicine specialists or endocrinologists with specialized expertise.

Response times for medical questions range from 24-48 hours for basic platforms to same-day response for premium services. Emergency medical support availability also varies, with some platforms providing 24/7 access to healthcare providers.

Patient Experience and Reviews

Patient satisfaction data reveals important differences in user experience across platforms. Review aggregation from multiple sources shows distinct patterns in patient feedback and outcomes.

Hims receives consistent praise for simplicity and reliability, with patients appreciating the straightforward approach. Common complaints focus on limited support for side effect management and higher pricing compared to alternatives.

Ro earns positive reviews for affordability and customer service, though some patients report feeling rushed through the consultation process. The platform's focus on cost-effectiveness appeals to budget-conscious users.

Calibrate generates strong patient satisfaction scores for comprehensive support and insurance assistance. However, some users find the program overwhelming or time-intensive, particularly those seeking simple medication access.

Found receives positive feedback for behavioral support and physician quality, though some patients report inconsistent coaching experiences. The platform's psychological approach resonates well with users who have struggled with emotional eating.

Noom benefits from its established user base and proven behavioral platform, though medical oversight receives mixed reviews. Users appreciate the app's functionality but sometimes feel the medical component is underdeveloped.

Sequence earns high marks for medical care quality and personalized attention, though pricing concerns appear frequently in reviews. Patients value the comprehensive approach but question whether premium features justify the cost.

Common themes across platforms include shipping reliability, customer service responsiveness, and physician accessibility. Most users report successful weight loss outcomes, though results vary based on individual factors and adherence to treatment protocols.

Which Is Right for You?

Choosing the right GLP-1 platform depends on your specific needs, budget, and preferences for medical oversight and support services.

Choose Ro if: You want the most affordable option with reliable medication access and don't need extensive coaching or support services. Ideal for straightforward cases with minimal comorbidities.

Choose Calibrate if: You want comprehensive weight management with lifestyle coaching, nutritional guidance, and strong insurance support. Best for patients seeking holistic approach to weight loss.

Choose Found if: You struggle with emotional eating or have psychological factors contributing to weight gain. The behavioral psychology focus makes this ideal for patients who have failed with diet-only approaches.

Choose Noom if: You want proven behavioral intervention with GLP-1 support but don't need tirzepatide access. Good for patients who respond well to app-based coaching and community support.

Choose Hims if: You prefer a simple, direct approach with established telehealth infrastructure and don't mind paying slightly more for convenience and reliability.

Choose Sequence if: You want premium medical care with board-certified specialists and comprehensive metabolic optimization. Best for complex cases or patients who prioritize medical expertise.

For patients seeking an alternative to these mainstream platforms, FormBlends offers physician-supervised GLP-1 therapy with personalized compounding options and competitive pricing. Our clinical team focuses on individualized treatment protocols and comprehensive patient support.

Frequently Asked Questions

How do I know if I qualify for GLP-1 medications?

Most platforms require a BMI of 30 or higher, or BMI of 27 with weight-related health conditions like diabetes or hypertension. Some platforms have additional criteria based on medical history and current medications. The initial consultation will determine eligibility based on FDA guidelines and platform-specific requirements.

What's the difference between compounded and brand-name GLP-1 medications?

Brand-name medications like Ozempic and Wegovy are FDA-approved with standardized dosing, while compounded versions are made by specialized pharmacies with flexible dosing options. Both contain the same active ingredients, but compounded versions often cost less and allow for more personalized dosing protocols.

How long does it take to see weight loss results?

Most patients begin seeing weight loss within 4-6 weeks of starting GLP-1 therapy. Significant results typically appear after 12-16 weeks of treatment. Individual results vary based on starting weight, adherence to treatment, lifestyle factors, and medication dosage.

Can I switch between platforms if I'm not satisfied?

Yes, you can switch platforms, though you'll need a new consultation and prescription from the new provider. Some platforms offer satisfaction guarantees or trial periods. Consider timing switches carefully to avoid gaps in medication access.

Do these platforms accept insurance for GLP-1 medications?

Insurance acceptance varies significantly. Calibrate and Found offer the strongest insurance support and prior authorization assistance. Other platforms typically require cash payment, though some provide insurance reimbursement documentation for potential partial coverage.

Ready to Start Your Weight Loss Goals?

Choosing the right GLP-1 platform is an important decision that should align with your medical needs, budget, and support preferences. Each platform offers distinct advantages, from Ro's affordability to Sequence's premium medical care.

Before making your final decision, consider scheduling consultations with multiple platforms to compare their approaches and determine which feels right for your situation. Many platforms offer initial consultations at no cost, allowing you to evaluate their medical team and treatment philosophy.

If you're looking for personalized physician oversight with competitive pricing, consider FormBlends' free physician assessment. Our clinical team specializes in individualized GLP-1 protocols and comprehensive patient support throughout your weight loss process.

Remember that successful weight loss with GLP-1 medications requires commitment to the treatment protocol, regular medical oversight, and often lifestyle modifications. Choose a platform that provides the level of support you need to achieve your long-term weight management goals.

Sources

Clinical Studies:

• Wilding, J.P.H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989-1002.
• Jastreboff, A.M., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205-216.

Platform Information:

• Hims & Hers Health, Inc. Weight Loss Program Details. Accessed March 2025.
• Ro (Roman) Weight Management Services. Accessed March 2025.
• Calibrate Health Program Information. Accessed March 2025.
• Found Weight Loss Platform Details. Accessed March 2025.
• Noom Med GLP-1 Program Information. Accessed March 2025.
• Sequence Weight Management Services. Accessed March 2025.